BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23176219)

  • 1. Non-ACE pathway-induced angiotensin II production.
    Uehara Y; Miura S; Yahiro E; Saku K
    Curr Pharm Des; 2013; 19(17):3054-9. PubMed ID: 23176219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiological roles of human chymase].
    Nakayama S; Urata H; Arakawa K
    Nihon Rinsho; 1997 Aug; 55(8):1903-8. PubMed ID: 9284400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiotensin II formation by chymase in the cardiovascular tissue].
    Okunishi H
    Nihon Yakurigaku Zasshi; 1998 Sep; 112(3):203-12. PubMed ID: 9793075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chymase-dependent angiotensin II forming systems in humans.
    Urata H; Nishimura H; Ganten D
    Am J Hypertens; 1996 Mar; 9(3):277-84. PubMed ID: 8695029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II-generating enzymes.
    Belova LA
    Biochemistry (Mosc); 2000 Dec; 65(12):1337-45. PubMed ID: 11173502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease.
    Reyes S; Varagic J; Ahmad S; VonCannon J; Kon ND; Wang H; Groban L; Cheng CP; Dell'Italia LJ; Ferrario CM
    Curr Hypertens Rep; 2017 Feb; 19(2):16. PubMed ID: 28233239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional evidence for a role of vascular chymase in the production of angiotensin II in isolated human arteries.
    Richard V; Hurel-Merle S; Scalbert E; Ferry G; Lallemand F; Bessou JP; Thuillez C
    Circulation; 2001 Aug; 104(7):750-2. PubMed ID: 11502696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme.
    Ahmad S; Varagic J; VonCannon JL; Groban L; Collawn JF; Dell'Italia LJ; Ferrario CM
    Biochem Biophys Res Commun; 2016 Sep; 478(2):559-64. PubMed ID: 27465904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase.
    Miyazaki M; Takai S
    J Pharmacol Sci; 2006; 100(5):391-7. PubMed ID: 16799256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of angiotensin II formation in humans.
    Urata H; Nishimura H; Ganten D
    Eur Heart J; 1995 Dec; 16 Suppl N():79-85. PubMed ID: 8682066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid. Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(1-9) formed by heart carboxypeptidase A-like activity.
    Kokkonen JO; Saarinen J; Kovanen PT
    Circulation; 1997 Mar; 95(6):1455-63. PubMed ID: 9118513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.
    Urata H; Kinoshita A; Misono KS; Bumpus FM; Husain A
    J Biol Chem; 1990 Dec; 265(36):22348-57. PubMed ID: 2266130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin I converting enzyme and chymase in cardiovascular tissues.
    Nishimura H; Hoffmann S; Baltatu O; Sugimura K; Ganten D; Urata H
    Kidney Int Suppl; 1996 Jun; 55():S18-23. PubMed ID: 8743505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative pathways for angiotensin II generation in the cardiovascular system.
    Becari C; Oliveira EB; Salgado MC
    Braz J Med Biol Res; 2011 Sep; 44(9):914-9. PubMed ID: 21956534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart.
    Wolny A; Clozel JP; Rein J; Mory P; Vogt P; Turino M; Kiowski W; Fischli W
    Circ Res; 1997 Feb; 80(2):219-27. PubMed ID: 9012744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue angiotensin II system in the human heart.
    Urata H; Hoffmann S; Ganten D
    Eur Heart J; 1994 Dec; 15 Suppl D():68-78. PubMed ID: 7713117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations.
    Balcells E; Meng QC; Johnson WH; Oparil S; Dell'Italia LJ
    Am J Physiol; 1997 Oct; 273(4):H1769-74. PubMed ID: 9362242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chymase: its pathophysiological roles and inhibitors.
    Fukami H; Okunishi H; Miyazaki M
    Curr Pharm Des; 1998 Dec; 4(6):439-53. PubMed ID: 10197055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.
    Urata H; Ganten D
    Eur Heart J; 1993 Nov; 14 Suppl I():177-82. PubMed ID: 8293772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracrine angiotensin II functions originate from noncanonical pathways in the human heart.
    Ferrario CM; Ahmad S; Varagic J; Cheng CP; Groban L; Wang H; Collawn JF; Dell Italia LJ
    Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H404-14. PubMed ID: 27233763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.